Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial recombinant high-density protein nanocarriers for precision drug delivery.

Chemical science·2026
Same author

Boosting immunogenic tumour cell death via nanotherapeutic targeting of the Stanniocalcin 1 phagocytosis checkpoint for enhanced cancer immunotherapy.

Nature communications·2026
Same author

Biomimetic liposomes in drug delivery: from design mechanisms to applications.

Chemical Society reviews·2025
Same author

Advances in nanotechnology-enabled adjuvants for peptide-based cancer vaccines.

Nano research·2025
Same author

A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer.

Nature cancer·2025
Same author

Sphingomyelin-derived epacadostat nanovesicle enhances IDO1 inhibition for improved melanoma combination immunotherapy.

Genes and immunity·2024

Related Experiment Video

Updated: May 27, 2025

Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis
09:17

Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis

Published on: August 24, 2017

7.7K

Liposome-Enabled Nanomaterials for Muscle Regeneration.

Shuang Wu1, Jianqin Lu1,2,3,4

  • 1Skaggs Pharmaceutical Sciences Center, Department of Pharmacology & Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ, 85721, USA.

Small Methods
|February 19, 2025
PubMed
Summary

Liposome nanotechnology offers a promising approach for muscle regeneration, aiding in treating conditions like sarcopenia and muscular dystrophy by improving drug delivery and reducing side effects.

Keywords:
liposomemuscle regenerationmuscle regeneration nanomedicinenanomedicine

More Related Videos

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

7.5K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.1K

Related Experiment Videos

Last Updated: May 27, 2025

Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis
09:17

Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis

Published on: August 24, 2017

7.7K
Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

7.5K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.1K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Nanotechnology

Background:

  • Muscle regeneration is essential for maintaining muscle function, especially in diseases like sarcopenia and muscular dystrophy.
  • While muscle tissue has self-repair capabilities, severe injuries and progressive diseases pose significant challenges.
  • Liposome-based nanotechnologies are emerging as potential therapeutic strategies for muscle regeneration.

Purpose of the Study:

  • To review recent advancements in liposome-based nanotechnologies for muscle regeneration.
  • To discuss current applications and underlying mechanisms of liposomes in treating muscle diseases.
  • To highlight challenges and future directions for clinical translation of liposome-nanomedicine.

Main Methods:

  • Literature review of recent advancements in liposome-based nanotechnologies for muscle regeneration.
  • Analysis of current applications and mechanisms of liposomes in muscle disease treatment.
  • Identification of challenges and future prospects for clinical translation.

Main Results:

  • Liposomes provide an adaptable platform for targeted drug delivery due to their biocompatibility and cell membrane-like structure.
  • Liposomes enhance drug solubility, stability, and targeted delivery, while minimizing systemic side effects.
  • Recent advancements show significant potential for liposome-enabled nanomedicine in muscle regeneration.

Conclusions:

  • Liposome-based nanotechnologies present a promising avenue for enhancing muscle regeneration therapies.
  • Further research and development are needed to overcome challenges for successful clinical translation.
  • Liposome-enabled nanomedicine holds potential to address current limitations in treating muscle diseases.